Table 1 Characteristics of the clinical pathway and patients.
Clinical pathway (CP) (nc = 61) | |
|---|---|
Implementation year, n (%) | |
2006 | 1 (2) |
2007 | 2 (3) |
2008 | 9 (15) |
2009 | 7 (11) |
2010 | 16 (26) |
2011 | 7 (11) |
2012 | 11 (18) |
2013 | 4 (7) |
2014 | 1 (2) |
2015 | 3 (5) |
Recommended length of stay, days, n (%) | |
1 | 24 (39) |
2 | 2 (3) |
3 | 17 (28) |
4 | 8 (13) |
5 | 3 (5) |
6 | 3 (5) |
7 | 1 (2) |
8 | 1 (2) |
9 | 1 (2) |
10 | 1 (2) |
Recommended duration of prophylactic antibiotics, day, n (%) | |
1 | 17 (28) |
2 | 16 (26) |
3 | 28 (46) |
Number of eligible patients per CP, median (min–max) | 339 (53–5277) |
Patients (np = 44,062) | |
Age, median (min–max) | 45 (0–99) |
Gender, n (%) | |
Male | 17,643 (40) |
Female | 26,419 (60) |
Relative admission date to CP implementation date, n (%) | |
− 2 year ~ − 1 year | 9690 (22) |
− 1 year ~ CP implementation | 10,903 (25) |
CP implementation ~ + 1 year | 11,451 (26) |
+ 1 to + 2 year | 12,018 (27) |
Number of patients whom CP was applied to | 19,293 (44%) |
Number of patients whom CP was completed for | 16,406 (37%) |
